Physician profile
Suzanne Clarke
NPI 1063470896
$1,371.38
in general payments reported to CMS, 2019-2025
20 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $223 · 2021: $421 · 2022: $40.56 · 2024: $38.11 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $192.68 | 2019-2025 | Otezla, Repatha |
| Pfizer INC. | $152.64 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $147.89 | 2019-2025 | Farxiga |
| Abbvie INC. | $130.51 | 2021-2025 | |
| Lilly USA, LLC | $126.29 | 2019-2025 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $82.05 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $75.48 | 2020 | |
| Merck Sharp & Dohme LLC | $75.11 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.65 | 2020-2025 | Jardiance |
| Novo Nordisk INC | $74.14 | 2020-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $53.68 | 2020-2021 | |
| Abbott Laboratories | $42.99 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $29.47 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $19.78 | 2024 | Uptravi, Opsumit |
| Dexcom, INC. | $18.33 | 2025 | Dexcom G6 Transmitter |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $17.32 | 2019 | |
| Exact Sciences Corporation | $16.28 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $15.48 | 2025 | Shingrix |
| Ge Healthcare | $14.19 | 2019 | |
| Astellas Pharma US INC | $12.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Clarke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.